Product
iN1011-N17 Mesylate
Aliases
iN1011-N17 Mesylate Capsule (Part 2), iN1011-N17 Mesylate Capsule (Part 3)
1 clinical trial
5 indications
Indication
Postherpetic NeuralgiaIndication
PainIndication
OsteoarthritisIndication
Neuropathic PainIndication
Chronic PainClinical trial
A Randomized, Double-blind, Placebo-controlled, Multiple-Ascending Dose Phase 1b Study to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Properties of iN1011-N17 After Oral Administration in Healthy Volunteers and Post-Herpetic Neuralgia Patients and to Assess the Relative Bioavailability of Mesylate vs Hydrochloride Salt Capsules in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-02-08